Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France

References

• British Lung Foundation. Chronic obstructive pulmonary disease (COPD) statistics [Internet]. 2011. Available from: https://statistics.blf.org.uk/copd
   Google Scholar
• Pauwels R. COPD: the scope of the problem in Europe. Chest. 2000;117(5 Suppl 2):332S–335S.
   PubMed Web of Science ®Google Scholar
• Direction des études de l’évaluation et des statistiques. L’état de santé de la population en France – Suivi des objectifs annexés à la loi de santé publique – Rapport [Internet]. 2011 [cited 2018 Oct 3]. Available from: http://drees.social-sante.gouv.fr/IMG/pdf/etat_sante_2011.pdf
   Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Fuhrman C, Delmas MC, pour le groupe epidemiologie et recherche clinique de la S. [Epidemiology of chronic obstructive pulmonary disease in France]. Rev Mal Respir. 2010;27(2):160–168.
   PubMed Web of Science ®Google Scholar
• Laurendeau C, Chouaid C, Roche N, et al. [Management and costs of chronic pulmonary obstructive disease in France in 2011]. Rev Mal Respir. 2015;32(7):682–691.
   PubMed Web of Science ®Google Scholar
• Molimard M, Raherison C, Lignot S, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49:1601794.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–577.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide to COPD Diagnosis, Management, and Prevention – 2016 [Internet]. 2015 [cited 2018 Oct 3]. Available from: http://goldcopd.org/pocket-guide-copd-diagnosis-management-prevention-2016/
   Google Scholar
• Bender BG. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next? Curr Opin Pulm Med. 2014;20(2):132–137.
   PubMed Web of Science ®Google Scholar
• Lareau SC, Hodder R. Teaching inhaler use in chronic obstructive pulmonary disease patients. J Am Acad Nurse Pract. 2012;24(2):113–120.
   PubMed Web of Science ®Google Scholar
• Pfarr C, Schmid A, Schneider U. Using discrete choice experiments to understand preferences in health care. Dev Health Econ Public Policy. 2014;12:27–48.
   PubMedGoogle Scholar
• Ryan M. Discrete choice experiments in health care. BMJ. 2004;328(7436):360–361.
   PubMed Web of Science ®Google Scholar
• FDA. Patient Preference Information – Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests and Inclusion in Decision Summaries and Device Labeling 2016 [Internet]. 2016 [cited 2018 Oct 26]. Available from: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm446680.pdf
   Google Scholar
• Hughes D, Waddingham E, Mt-Isa S, et al. Recommendations for benefit–risk assessment methodologies and visual representations. Pharmacoepidemiol Drug Saf. 2016;25(3):251–262.
   PubMed Web of Science ®Google Scholar
• Hawken NA, Aballéa S, Torvinen S, et al. Identification of dry powder inhaler attributes, and their relative importance to asthma and chronic obstructive pulmonary disease patients, to inform a discrete choice experiment. Value Health. 17(7):A600.
   PubMed Web of Science ®Google Scholar
• Kawata AK, Kleinman L, Harding G, et al. Evaluation of patient preference and willingness to pay for attributes of maintenance medication for chronic obstructive pulmonary disease (COPD). Patient. 2014;7(4):413–426.
   PubMedGoogle Scholar
• Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13.
   PubMed Web of Science ®Google Scholar
• Akaike A. Information theory and an extension of the maximum likelihood principle. In: Parzen E, Tanabe K, Kitagawa G, editors. Selected papers of Hirotugu Akaike. New York (NY): Springer; 1998. p. 199–213.
   Google Scholar
• Ding B, Small M, Scheffel G, et al. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927–936.
   PubMed Web of Science ®Google Scholar
• Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28(3):219–228.
   PubMed Web of Science ®Google Scholar
• Éléments pour élaborer une aide à la prise de décision partagée entre patient et professionnels de santé [Internet]. 2018. [cited 2018 Oct 3] Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2018-03/elaborer_une_aide_a_la_prise_de_decision_partagee_mel.pdf
   Google Scholar
• Lavorini F, Fontana GA, Usmani OS. New inhaler devices – the good, the bad and the ugly. Respiration. 2014;88(1):3–15.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN, Lavorini F, Usmani OS. Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat or HandiHaler. Patient Prefer Adherence. 2016;10:1561–1572.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Montero-Caballero J, Richard F, et al. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:407–415.
   PubMed Web of Science ®Google Scholar
• Oliveira MVC, Pizzichini E, da Costa CH, et al. Evaluation of the preference, satisfaction and correct use of Breezhaler and Respimat inhalers in patients with chronic obstructive pulmonary disease – INHALATOR study. Respir Med. 2018;144:61–67.
   PubMed Web of Science ®Google Scholar
• Perez T, Serrier P, Pribil C, et al. [COPD and quality of life: impact of the disease in primary care in France]. Rev Mal Respir. 2013;30(1):22–32.
   PubMed Web of Science ®Google Scholar
• Piperno D, Huchon G, Pribil C, et al. The burden of COPD in France: results from the Confronting COPD survey. Respir Med. 2003;97(Suppl C):S33–S42.
   PubMed Web of Science ®Google Scholar
• Roche N, Pribil C, Van Ganse E, et al. Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med. 2014;14:56.
   PubMed Web of Science ®Google Scholar